Diagnosis of deep vein thrombosis of the upper extremity: a systematic review and meta-analysis of test accuracy.
Journal
Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425
Informations de publication
Date de publication:
09 06 2020
09 06 2020
Historique:
received:
26
12
2019
accepted:
30
04
2020
entrez:
9
6
2020
pubmed:
9
6
2020
medline:
11
5
2021
Statut:
ppublish
Résumé
Upper extremity deep vein thrombosis (UEDVT) accounts for ≤10% of DVT and can be associated with morbidity and mortality. Accurate diagnosis and treatment are necessary for safe and effective patient management. We systematically reviewed the accuracy of D-dimer and duplex ultrasonography (US) for the evaluation of suspected first-episode UEDVT. We searched the Cochrane Central Register, OVID MEDLINE, EMBASE, and PubMed for eligible studies, reference lists of relevant reviews, registered trials, and relevant conference proceedings. We included prospective cross-sectional and cohort studies that evaluated test accuracy. Two investigators independently screened and collected data. The risk of bias was assessed using Quality Assessment of Diagnostic Accuracy Studies 2 and certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation framework. We pooled estimates of sensitivity and specificity. The review included 9 studies. The pooled estimates for D-dimer sensitivity and specificity were 0.96 (95% confidence interval [CI], 0.87-0.99) and 0.47 (95% CI, 0.43-0.52), respectively. The pooled estimates for duplex US sensitivity and specificity were 0.87 (95% CI, 0.73-0.94) and 0.85 (95% CI, 0.72-0.93), respectively. Certainty of evidence was moderate. In this review, we summarized the test accuracy (sensitivity and specificity) of D-dimer and duplex US for this indication. The sensitivity and specificity of the tests found in the present review should be considered in the context of whether they are used alone or in combination, which is dependent on the prevalence of disease in the population, the clinical setting in which the patient is being evaluated, cost, potential harms, and patient outcomes. This study was registered at PROSPERO as Systematic Review Registration Number CRD42018098488.
Identifiants
pubmed: 32511715
pii: S2473-9529(20)31278-7
doi: 10.1182/bloodadvances.2019001409
pmc: PMC7284086
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2516-2522Informations de copyright
© 2020 by The American Society of Hematology.
Références
Semin Thromb Hemost. 2002 Feb;28(1):89-99
pubmed: 11885029
Thromb Res. 2010 Sep;126(3):195-9
pubmed: 20580416
Clin Sci (Lond). 1998 Jun;94(6):657-61
pubmed: 9854465
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
Thromb Haemost. 2008 Jan;99(1):202-7
pubmed: 18217155
Thromb Res. 2015 Apr;135(4):673-8
pubmed: 25700619
ACP J Club. 2008 Dec 16;149(6):2
pubmed: 19071869
Blood Coagul Fibrinolysis. 2006 Apr;17(3):225-6
pubmed: 16575263
BMJ. 2008 May 17;336(7653):1106-10
pubmed: 18483053
Ann Intern Med. 2014 Apr 1;160(7):451-7
pubmed: 24687068
Br J Radiol. 1991 Sep;64(765):777-81
pubmed: 1913037
Surgery. 1982 May;91(5):582-5
pubmed: 7071746
J Clin Oncol. 2003 Oct 1;21(19):3665-75
pubmed: 14512399
Ann Intern Med. 2002 Jun 18;136(12):865-72
pubmed: 12069560
Clin Radiol. 1995 Oct;50(10):687-9
pubmed: 7586960
Blood Adv. 2018 Nov 27;2(22):3226-3256
pubmed: 30482764
J Vasc Surg. 1991 Mar;13(3):391-7
pubmed: 1999858
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
BMJ. 2014 Mar 10;348:g1340
pubmed: 24615063
Arch Intern Med. 1997 Jan 13;157(1):57-62
pubmed: 8996041
J Thromb Haemost. 2005 Nov;3(11):2409-19
pubmed: 15975139